# OnCo record scot (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/scot/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "scot", "ISRCTN59757862" ;
  schema:name "SCOT"@en ;
  schema:alternateName "Short Course Oncology Therapy"@en, "ISRCTN59757862"@en ;
  schema:description "The Glasgow-led trial that halved the length of chemotherapy after bowel cancer surgery, sparing thousands of people lasting nerve damage."@en ;
  schema:url <https://onco.cc/trials/scot/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://europepmc.org/article/MED/29611518>, <https://www.isrctn.com/ISRCTN59757862> ;
  onco:status "positive" ;
  onco:tag "uk", "adjuvant", "colorectal", "de-escalation" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/capecitabine/> ;
  onco:institutions <https://onco.cc/institutions/beatson-glasgow/>, <https://onco.cc/institutions/oxford-cancer/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/de-escalation/> ;
  onco:trials <https://onco.cc/trials/idea-collaboration/> ;
  onco:people <https://onco.cc/people/rachel-kerr/> .